Suministro medicamento mycobacterium bovis bcg
About This Opportunity
Chile contract award (healthcare): Suministro medicamento mycobacterium. By Chile Mercadopublico. Awarded to LABORATORIOS ANDROMACO S.A. (CLP 91.4M, Feb 2026).
This is a supplies contract in the health and medical services, finance and banking and trade and industry sectors, with a focus on Pharmaceuticals, Vaccines, Infectious Diseases and Manufacturing. Located in Chile, Latin America, this opportunity is open to firms and consortiums.
Published through Chile Mercado Publico, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
This tender, originating from Chile and published on the chile_mercadopublico platform, seeks the supply of the Mycobacterium bovis BCG (Bacillus Calmette-Guérin) medication. The contracting authority, likely a public health or governmental entity within Chile, requires a reliable and consistent provision of this essential pharmaceutical product.
The procurement focuses on acquiring a specific biological agent used primarily as a vaccine against tuberculosis. Suppliers are expected to demonstrate their capability to meet the stringent quality and regulatory standards associated with pharmaceutical manufacturing and distribution. Typical requirements for such tenders include adherence to Good Manufacturing Practices (GMP), provision of detailed product specifications, Certificates of Analysis (CoA), and evidence of relevant national and international regulatory approvals. Furthermore, bidders will likely need to outline their logistical capabilities for secure storage, transportation, and timely delivery to designated points of use within Chile.
Experience in supplying similar biological or pharmaceutical products to public health systems may be a key consideration. The tender will evaluate proposals based on factors such as product quality, compliance with specifications, delivery timelines, and competitive pricing. Successful bidders will be responsible for ensuring the integrity and efficacy of the Mycobacterium bovis BCG medication throughout the supply chain, contributing to public health initiatives in Chile.
Data provenance
This notice is sourced from Chile Mercado Publico and was originally published on March 7, 2026. Last refreshed 1 day ago. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
Frequently asked questions about this tender
Where will the contract be performed?
The contract is for delivery in Chile. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit Chile Mercado Publico to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to LABORATORIOS ANDROMACO S.A.. The award notice is archived on BidsFactory for transparency and market intelligence.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
How much was the contract awarded for?
LABORATORIOS ANDROMACO S.A. was awarded the contract for CLP 91,411,200. The figure reflects the value disclosed by the contracting authority in the award notice.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.